Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma

2 Feb 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36736507
DOI: 10.1016/j.gene.2023.147233

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastomaPMID 36736507Read ↗

Germline Functional Variants Contribute to Somatic Mutation and Outcomes in NeuroblastomaSemantic proximity Read ↗

Germline functional variants contribute to somatic mutation and outcomes in neuroblastoma.Semantic proximity Read ↗

The genetic landscape of high-risk neuroblastoma.Semantic proximity Read ↗

Germline pathogenic variants in 786 neuroblastoma patientsSemantic proximity Read ↗

Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors.Semantic proximity Read ↗

Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.Semantic proximity Read ↗

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.Semantic proximity Read ↗

Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastomaSemantic proximity Read ↗

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.